4.2 Article

Spectrum of MLL2 (ALR) Mutations in 110 Cases of Kabuki Syndrome

期刊

AMERICAN JOURNAL OF MEDICAL GENETICS PART A
卷 155A, 期 7, 页码 1511-1516

出版社

WILEY-BLACKWELL
DOI: 10.1002/ajmg.a.34074

关键词

Kabuki syndrome; MLL2; ALR; Trithorax group histone methyltransferase

资金

  1. National Institutes of Health/National Heart Lung and Blood Institute [5R01HL094976]
  2. National Institutes of Health/National Human Genome Research Institute [5R21HG004749, 1RC2HG005608, 5RO1HG004316, T32HG00035]
  3. National Institute of Heath/National Institute of Environmental Health Sciences [HHSN273200800010C]
  4. National Institute of Neurological Disorders and Stroke [RO1NS35102]
  5. NIHR Manchester Biomedical Research Centre
  6. Ministry of Health, Labour and Welfare of Japan
  7. Japan Science and Technology Agency
  8. Society for the Promotion of Science
  9. Life Sciences Discovery Fund [2065508, 0905001]
  10. Washington Research Foundation
  11. National Institutes of Health/National Institute of Child Health and Human Development [1R01HD048895, 5K23HD057331]
  12. Ministry of Health, Labour and Welfare
  13. Agency for Science, Technology and Research, Singapore
  14. Grants-in-Aid for Scientific Research [23590383, 21390100, 23689052, 22659071, 23591506] Funding Source: KAKEN

向作者/读者索取更多资源

Kabuki syndrome is a rare, multiple malformation disorder characterized by a distinctive facial appearance, cardiac anomalies, skeletal abnormalities, and mild to moderate intellectual disability. Simplex cases make up the vast majority of the reported cases with Kabuki syndrome, but parent-to-child transmission in more than a half-dozen instances indicates that it is an autosomal dominant disorder. We recently reported that Kabuki syndrome is caused by mutations in MLL2, a gene that encodes a Trithorax-group histone methyltransferase, a protein important in the epigenetic control of active chromatin states. Here, we report on the screening of 110 families with Kabuki syndrome. MLL2 mutations were found in 81/110 (74%) of families. In simplex cases for which DNA was available from both parents, 25 mutations were confirmed to be de novo, while a transmitted MLL2 mutation was found in two of three familial cases. The majority of variants found to cause Kabuki syndrome were novel nonsense or frameshift mutations that are predicted to result in haploinsufficiency. The clinical characteristics of MLL2 mutation-positive cases did not differ significantly from MLL2 mutation-negative cases with the exception that renal anomalies were more common in MLL2 mutation-positive cases. These results are important for understanding the phenotypic consequences of MLL2 mutations for individuals and their families as well as for providing a basis for the identification of additional genes for Kabuki syndrome. (C) 2011 Wiley-Liss, Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据